CUMBERLAND PHARMACEUTICALS INC.

Insiders Cumberland Pharmaceuticals Inc.

Equities

CPIX

US2307701092

Market Closed - Nasdaq Other stock markets 04:30:00 2024-04-29 pm EDT			5-day change	1st Jan Change
1.695 ^USD	-3.69%		+3.35%	-5.40%

Mar. 13	Tranche Update on Cumberland Pharmaceuticals Inc.'s Equity Buyback Plan announced on May 13, 2010.	CI
Mar. 05	Cumberland Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Cumberland Pharmaceuticals Inc. Announces Demise of Joey A. Jacobs, Member of Board of Directors	23-01-17	CI
Cumberland Pharmaceuticals Appoints Martin Brown Jr. to Its Board of Directors	22-07-19	CI
Cumberland Pharmaceuticals Inc. Announces Executive Changes	22-06-03	CI
Cumberland Pharmaceuticals Inc. Announces Executive Changes	22-03-22	CI
Cumberland Pharmaceuticals Inc. Promotes John Hamm to Director Finance Accounting	21-05-20	CI
Cumberland Pharmaceuticals Inc. Names John Hamm as Chief Financial Officer	21-05-19	CI
Cumberland Pharmaceuticals Inc. Appoints John Hamm as the Senior Director Finance & Accounting, Effective May 17, 2021	21-05-14	CI
Cumberland Pharmaceuticals Inc. Appoints Caroline R. Young as First ESG Board Director	20-05-20	CI
Martin E. Cearnal Resigns as Class III Director of Cumberland Pharmaceuticals Inc	19-09-20	CI
Cumberland Pharmaceuticals Inc. Appoints Joseph C. Galante as Member of Board of Directors	18-09-21	CI
Cumberland Pharmaceuticals Appoints Adam Haeberle as Senior Director, Clinical and Regulatory Affairs	18-08-13	CI
Cumberland Pharmaceuticals Inc. Appoints Chris Bitterman as Hospital Sales Director	18-05-07	CI
Cumberland Pharmaceuticals Appoints Kenneth J. Krogulski to Board of Directors, Effective January 18, 2017	17-01-16	CI
Cumberland Pharmaceuticals Announces the Addition of Caroline Young to its Board of Directors	16-06-10	CI
Cumberland Pharmaceuticals Inc. Promotes Amy D. Rock to Vice President, Regulatory & Scientific Affairs	16-02-05	CI
Cumberland Pharmaceuticals Inc. Appoints Michael Bonner as Senior Director Finance and Accounting and Chief Financial Officer Effective February 1, 2016	16-02-01	CI
Cumberland Pharmaceuticals, Inc. Announces Executive Changes	15-10-02	CI
Cumberland Pharmaceuticals, Inc. : Cumberland Pharmaceuticals Named in Mordern Healthcare's Inaugural Healthcare's Hottest Recognition Program	12-08-23	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Securing my Investments

fermer